tirzepatide and kidney disease GLP therapies have established themselves as kidney-protective in type 2 diabetes high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney protection with (#mounjaro) Interplay of Chronic Kidney Disease

Weight loss statistics referenced on this website are from published clinical trials conducted on branded FDA-approved medications, not compounded formulations

The key is to keep your portion size small (around 23 cups) and avoid sugary or buttery toppings that could cause a spike

Thats the time when your body should fully adjust to the medication, so youll begin to notice a reduction in body weight

However, its always best to be cautious and ask your doctor to review your specific situation

In other words, if youve been prescribing compounded versions of Tirzepatide, its time to start looking at the commercially available products again or prescribe a compounded alternative

This is one of the most common questions I hear, and the honest answer is: it depends